MedCity News November 12, 2024
Experts agree that the incoming Trump administration will likely shake things up in the prescription drug world — most notably when it comes to research and development, drug pricing and PBM reform.
Former President Donald Trump’s return to the White House is certain to bring about changes across many facets of the healthcare sector — including reproductive care, federal insurance programs and prescription drugs.
Experts interviewed for this article, who include pharmaceutical executives and healthcare consultants, agree that the upcoming Trump administration is likely to shake things up in the prescription drug world, most notably in the areas of drug pricing, and research and development.
What effects could tariffs have on research and development?
On the campaign trail, Trump often...
Today's Sponsors
Today's Sponsor